AI

R&D
artificial intelligence

Transforming drug development with AI

From streamlining clinical trials to evaluating drug repurposing possibilities for new patient populations and addressing critical supply chain challenges, 2024 will be the year artificial

R&D
JP Morgan 2024 – Jen Nwankwo

JP Morgan 2024 – Jen Nwankwo

While 2023 may have been the year of AI for the consumer consciousness, for companies using the technology in a focused way in drug development it was just another year of learning and adva